Gergő Szanda

2.2k total citations · 1 hit paper
39 papers, 1.8k citations indexed

About

Gergő Szanda is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Gergő Szanda has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Surgery. Recurrent topics in Gergő Szanda's work include Mitochondrial Function and Pathology (17 papers), Cannabis and Cannabinoid Research (11 papers) and ATP Synthase and ATPases Research (10 papers). Gergő Szanda is often cited by papers focused on Mitochondrial Function and Pathology (17 papers), Cannabis and Cannabinoid Research (11 papers) and ATP Synthase and ATPases Research (10 papers). Gergő Szanda collaborates with scholars based in Hungary, United States and Israel. Gergő Szanda's co-authors include András Spät, George Kunos, Reşat Çınar, Tony Jourdan, Joseph Tam, Grzegorz Godlewski, Bani Mukhopadhyay, Jie Liu, György Csordás and György Hajnóczky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Gergő Szanda

39 papers receiving 1.8k citations

Hit Papers

Activation of the Nlrp3 inflammasome in infiltrating macr... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gergő Szanda Hungary 20 886 642 408 387 349 39 1.8k
Tony Jourdan United States 24 497 0.6× 1.0k 1.6× 497 1.2× 558 1.4× 391 1.1× 38 2.0k
Oksana Kunduzova France 23 642 0.7× 546 0.9× 529 1.3× 113 0.3× 297 0.9× 44 1.8k
Christine Reynet United States 19 1.3k 1.5× 442 0.7× 534 1.3× 519 1.3× 428 1.2× 27 2.0k
Mariela M. Gironacci Argentina 26 663 0.7× 293 0.5× 157 0.4× 564 1.5× 199 0.6× 72 1.7k
Boris Julien France 17 466 0.5× 1.1k 1.7× 493 1.2× 337 0.9× 149 0.4× 20 2.4k
Mei Yu China 22 676 0.8× 189 0.3× 205 0.5× 153 0.4× 492 1.4× 45 1.4k
Julie L. Lavoie Canada 23 811 0.9× 175 0.3× 138 0.3× 444 1.1× 260 0.7× 47 1.9k
David J. Behm United States 26 415 0.5× 591 0.9× 573 1.4× 362 0.9× 226 0.6× 47 1.6k
Alexander M. Efanov Sweden 23 1.2k 1.4× 174 0.3× 1.1k 2.6× 469 1.2× 264 0.8× 40 2.0k
S. Narumiya Japan 18 690 0.8× 654 1.0× 194 0.5× 86 0.2× 360 1.0× 25 2.0k

Countries citing papers authored by Gergő Szanda

Since Specialization
Citations

This map shows the geographic impact of Gergő Szanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gergő Szanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gergő Szanda more than expected).

Fields of papers citing papers by Gergő Szanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gergő Szanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gergő Szanda. The network helps show where Gergő Szanda may publish in the future.

Co-authorship network of co-authors of Gergő Szanda

This figure shows the co-authorship network connecting the top 25 collaborators of Gergő Szanda. A scholar is included among the top collaborators of Gergő Szanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gergő Szanda. Gergő Szanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szanda, Gergő, et al.. (2023). Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB1 Receptor Antagonists after the Fall. SHILAP Revista de lepidopterología. 2(3). 689–707. 9 indexed citations
2.
Szanda, Gergő, Tony Jourdan, Éva Wisniewski, et al.. (2023). Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3. iScience. 26(7). 107207–107207. 3 indexed citations
3.
Wisniewski, Éva, et al.. (2021). Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor. Frontiers in Endocrinology. 12. 740913–740913. 3 indexed citations
4.
Drori, Adi, Shahar Azar, Liad Hinden, et al.. (2020). CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance. eLife. 9. 18 indexed citations
5.
Spät, András & Gergő Szanda. (2018). Mitochondrial cAMP and Ca2+ metabolism in adrenocortical cells. Pflügers Archiv - European Journal of Physiology. 470(8). 1141–1148. 3 indexed citations
6.
Çınar, Reşat, Bernadette R. Gochuico, Malliga R. Iyer, et al.. (2017). Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight. 2(8). 68 indexed citations
7.
Spät, András & Gergő Szanda. (2017). The Role of Mitochondria in the Activation/Maintenance of SOCE: Store-Operated Ca2+ Entry and Mitochondria. Advances in experimental medicine and biology. 993. 257–275. 7 indexed citations
8.
Paillard, M., György Csordás, Gergő Szanda, et al.. (2017). Tissue-Specific Mitochondrial Decoding of Cytoplasmic Ca 2+ Signals is Controlled by the Stoichiometry of MICU1/2 and MCU. Biophysical Journal. 112(3). 537a–537a. 1 indexed citations
9.
Spät, András, László Hunyady, & Gergő Szanda. (2016). Signaling Interactions in the Adrenal Cortex. Frontiers in Endocrinology. 7. 17–17. 26 indexed citations
10.
Çınar, Reşat, Malliga R. Iyer, Ziyi Liu, et al.. (2016). Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. JCI Insight. 1(11). 63 indexed citations
11.
Iyer, Malliga R., Reşat Çınar, Jie Liu, et al.. (2015). Structural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists. Molecular Pharmacology. 88(2). 238–244. 16 indexed citations
12.
Golenár, Tünde, György Csordás, Gergő Szanda, et al.. (2014). Control of Mitochondrial Ca2+ Uptake Threshold via the Micu1:Mcu Ratio. Biophysical Journal. 106(2). 591a–591a. 1 indexed citations
13.
Tam, Joseph, Reşat Çınar, Jie Liu, et al.. (2012). Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance. Cell Metabolism. 16(2). 167–179. 296 indexed citations
14.
Wiederkehr, Andreas, Gergő Szanda, Dmitry Akhmedov, et al.. (2011). Mitochondrial Matrix Calcium Is an Activating Signal for Hormone Secretion. Cell Metabolism. 13(5). 601–611. 130 indexed citations
15.
Koncz, P., et al.. (2009). Mitochondrial Ca2+ uptake is inhibited by a concerted action of p38 MAPK and protein kinase D. Cell Calcium. 46(2). 122–129. 20 indexed citations
16.
Korzeniowski, Marek, Gergő Szanda, Tamás Balla, & András Spät. (2009). Store-operated Ca2+ influx and subplasmalemmal mitochondria. Cell Calcium. 46(1). 49–55. 27 indexed citations
17.
Szanda, Gergő, et al.. (2008). Effect of cytosolic Mg2+ on mitochondrial Ca2+ signaling. Pflügers Archiv - European Journal of Physiology. 457(4). 941–954. 27 indexed citations
18.
Spät, András, Gergő Szanda, György Csordás, & György Hajnóczky. (2008). High- and low-calcium-dependent mechanisms of mitochondrial calcium signalling. Cell Calcium. 44(1). 51–63. 109 indexed citations
19.
Szanda, Gergő, et al.. (2007). Participation of p38 MAPK and a novel-type protein kinase C in the control of mitochondrial Ca2+ uptake. Cell Calcium. 43(3). 250–259. 34 indexed citations
20.
Szanda, Gergő, P. Koncz, Péter Várnai, & András Spät. (2006). Mitochondrial Ca2+ uptake with and without the formation of high-Ca2+ microdomains. Cell Calcium. 40(5-6). 527–537. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026